Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Status: Publicly traded
Direct answer
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is publicly traded on HKSE under the ticker 2315.HK.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., established in 2009 with its main office in Beijing, China, operates as a global biotechnology firm. Its core business involves the international research and development of antibody-based treatments. The company's drug development portfolio currently features a dozen key product candidates; specifically, two are actively progressing through multi-regional Phase II...
Can you invest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.?
Yes. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is publicly traded on HKSE under the ticker 2315.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Detailed equity research is provided by MarketSnap.